Blueprint Medicines Overview
Blueprint Medicines Target Price
Analysts' 12-month price predictions for BPMC.
Share Price
$106.64
Average Target Price
$112.00
5% upside
5% upside3 analysts in the last 4 months
High: $135 | Low: $97
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-06 | Leerink PartnersAndrew Berens | $97 |  9% downside |  |
| 2024-05-03 | Raymond JamesChristopher Raymond | $104 | 2.5% downside | |
| 2024-05-03 | H.C. WainwrightAndrew Fein | $135 | 26.6% upside | |
| 2022-12-14 | Needham | $60 | 43.7% downside | |
| 2022-11-02 | H.C. WainwrightAndrew Fein | $70 | 34.4% downside | |
| 2022-09-06 | OppenheimerMatthew Biegler | $90 | 15.6% downside | |
| 2022-08-17 | Wells FargoDerek Archila | $41 | 61.6% downside | |
| 2022-05-18 | Piper SandlerChristopher Raymond | $65 | 39% downside | |
| 2022-02-01 | Morgan StanleyMichael Ulz | $92 | 13.7% downside | |
| 2022-01-03 | GuggenheimMichael Schmidt | $122 | 14.4% upside | |
| 2021-11-09 | Raymond JamesDane Leone | $133 | 24.7% upside | |
| 2021-07-29 | Goldman SachsSalveen Richter | $147 | 37.8% upside | |
| 2021-06-17 | Canaccord GenuityArlinda Lee | $120 | 12.5% upside | |